BEVACIZUMAB — all Canadian products
15 DINs
15 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BEVACIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02522160 | ABEVMY | BIOCON BIOLOGICS CANADA INC | Solution | Intravenous | BEVACIZUMAB 400 MG | Marketed | |
| 02522179 | ABEVMY | BIOCON BIOLOGICS CANADA INC | Solution | Intravenous | BEVACIZUMAB 100 MG | Marketed | |
| 02270994 | AVASTIN | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous | BEVACIZUMAB 25 MG | Marketed | |
| 02522829 | AYBINTIO | SAMSUNG BIOEPIS CO., LTD | Solution | Intravenous | BEVACIZUMAB 100 MG | Marketed | |
| 02522837 | AYBINTIO | SAMSUNG BIOEPIS CO., LTD | Solution | Intravenous | BEVACIZUMAB 400 MG | Marketed | |
| 02520729 | BAMBEVI | APOTEX INC | Solution | Intravenous | BEVACIZUMAB 100 MG | Marketed | |
| 02520737 | BAMBEVI | APOTEX INC | Solution | Intravenous | BEVACIZUMAB 400 MG | Marketed | |
| 02567865 | BEVQOLVA | CURATEQ BIOLOGICS PRIVATE LIMITED | Solution | Intravenous | BEVACIZUMAB 400 MG | Approved | |
| 02567830 | BEVQOLVA | CURATEQ BIOLOGICS PRIVATE LIMITED | Solution | Intravenous | BEVACIZUMAB 100 MG | Approved | |
| 02470756 | MVASI | AMGEN CANADA INC | Solution | Intravenous | BEVACIZUMAB 25 MG | Marketed | |
| 02470748 | MVASI | AMGEN CANADA INC | Solution | Intravenous | BEVACIZUMAB 25 MG | Marketed | |
| 02534177 | VEGZELMA | CELLTRION INC. | Solution | Intravenous | BEVACIZUMAB 100 MG | Marketed | |
| 02534185 | VEGZELMA | CELLTRION INC. | Solution | Intravenous | BEVACIZUMAB 400 MG | Marketed | |
| 02489449 | ZIRABEV | PFIZER CANADA ULC | Solution | Intravenous | BEVACIZUMAB 400 MG | Marketed | |
| 02489430 | ZIRABEV | PFIZER CANADA ULC | Solution | Intravenous | BEVACIZUMAB 100 MG | Marketed |
Browse other molecules: